Rating Change
BTIG reiterated its Buy rating on Spyre Therapeutics, Inc. (NASDAQ:SYRE) on August 11, 2026.
reiterateNASDAQ:SYRE
BTIG Reiterates Buy Rating on Spyre Therapeutics, Inc. (SYRE)
BTIG reiterated its Buy rating on Spyre Therapeutics, Inc. (NASDAQ:SYRE) on August 11, 2026.
At publication ·
What changed
Spyre Therapeutics, Inc. (NASDAQ:SYRE) · reiterate
- Firm
- BTIG
- Rating
- Buy to Buy
- Price at event
- $101.80
- Market capitalization
- $2.1B
At a glance
Key takeaways
- BTIG reiterated its Buy rating on Spyre Therapeutics (SYRE) on August 11, 2026, with the stock trading at $101.80 and a market capitalization of $2.1 billion.
Market Context
Spyre Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $101.80 with a market capitalization of $2.1B.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Spyre Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Spyre Therapeutics, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | BTIG | Buy | N/A |
| Aug 05, 2026 | Wedbush | Outperform | N/A |
| Aug 05, 2026 | Guggenheim | Buy | N/A |
| Aug 05, 2026 | Wells Fargo | Overweight | N/A |
| Jul 28, 2026 | Wolfe Research | Peer Perform | N/A |
Related Tools: Analyst Ratings Dashboard | View SYRE Stock Page
Frequently Asked Questions
What does the Buy rating mean for SYRE?
A rating of Buy from BTIG reflects the analyst's outlook on Spyre Therapeutics, Inc. (NASDAQ:SYRE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SYRE forecast page.